ARGX:EBR
argenx SE
€758.60
arrow_upward
+1.66%(+12.40) 1H
15 Okt, 5:35:28 PTG GMT+2 · EUR
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk ARGX...
Buka
€740.40
Tinggi
€766.00
Rendah
€733.80
Permodalan Pasaran
46.53B
Purata volum
85.14K
Volum
108.86K
Nisbah H/P
32.27
tgi 52 mgu
€925.00
rdh 52 mgu
€568.40
EPS
€23.51
Syer tertunggak
35.93J
Bilangan pekerja
2K
Buka
€740.40
Tinggi
€766.00
Rendah
€733.80
Permodalan Pasaran
46.53B
Purata volum
85.14K
Volum
108.86K
Nisbah H/P
32.27
tgi 52 mgu
€925.00
rdh 52 mgu
€568.40
EPS
€23.51
Syer tertunggak
35.93J
Bilangan pekerja
2K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Investing.com South Africa
·
15 jam lalu
Argenx shares may move 5.5% on earnings release next week By Investing.com
ad-hoc-news.de
·
20 jam lalu
Wells Fargo sets USD 1,356 target for argenx stock
TipRanks
·
23 jam lalu
argenx Schedules Q3 2026 Results Call and Business Update
Pluang
·
1 hari lalu
argenx to report Q3 2026 financial results and business update on Oct 22
Profil
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
Perihal argenx SE